Suggestions
Michael Scheiner
Founder and CEO at Pharma14.com
Michael Scheiner, Founder of Pharma14.com
Michael Scheiner is the Founder of Pharma14.com, a pharmaceutical big data management company based in Israel.123 He holds a Bachelor of Science (BSc) degree from The Hebrew University of Jerusalem, which he obtained between 1990 and 1993.2
Scheiner has extensive experience in pharmaceutical big data management and e-commerce, digital and branding consulting.1 He founded Pharma14.com, a global medicine database and price index.
The Pharma14.com management team includes Michael Scheiner as Founder, Martin Kotik as Chief Business Development Officer, and Egor Litvin as Data Analyst.35 Scheiner's email address is [email protected], and his phone numbers are +1.2129679670 and +1.6464178178.46
Highlights
Maximizing Launch Success: How Our Database System Supports Optimal Pricing Strategies
As you navigate the complexities of launching new medicines, one of the most critical decisions you face is setting the correct launch price. This decision not only influences your product's market access but also has long-term implications for your revenue and competitive positioning, especially in tender markets where pricing dynamics can be particularly challenging.
The Importance of Data-Driven Pricing Strategies
In today’s rapidly evolving healthcare landscape, relying solely on traditional pricing strategies is no longer sufficient. Regulatory environments, reimbursement criteria, and market expectations are continuously shifting. To stay ahead, you need a pricing strategy that is informed by comprehensive, real-time data.
This is where our cutting-edge database system comes into play.
How Our System Supports Your Pricing Decisions
Our database system is designed to provide you with the insights you need to set the optimal launch price, taking into account the nuances of various markets, including highly competitive tender markets. Here’s how our system can benefit your pricing strategy:
Comprehensive Market Data: Access a vast repository of real-time market data, including competitor pricing, reimbursement rates, and market access conditions across multiple geographies. This enables you to benchmark your pricing strategy effectively.
Tender Market Insights: Understand the specific pricing dynamics of tender markets. Our system offers detailed insights into past tender outcomes, pricing trends, and key factors that influence winning bids, helping you position your product for success.
Predictive Analytics: Leverage advanced analytics to forecast pricing scenarios and outcomes. Our system models various pricing strategies, taking into account different regulatory and market variables, so you can identify the optimal price point that maximizes market share and revenue.
Case in point; Currently, the official and private ex-factory prices for Adalimumab are approximately EUR 70 for a single 20mg/0.4 mL injection. However, according to Pharma14’s latest tender data, low-end tender prices in major European markets, such as Italy and Spain, are already approaching the EUR 20 mark. These tenders are not only driving prices down but also securing contract durations of 4 to 5 years. Market projections suggest that this pricing trend will likely continue over the next 2-3 years, impacting the broader market landscape.
Pharma14 will be attending and showcasing its platform at the euroPLX in Lisbon on the 26 and 27th of this month.
A little about Pharma14. The Pharma14 database platform covers 70 countries and deals in the tracking of finished dosage formulations as well as business analysis tools. Our data has all registered medicines, prices, consumption data, reimbursement data and much more. Our data is refined, cleaned, standardized and translated so our search functions are the most exact in the industry.
Pharma14 full highlights: • 70 full country medicine database. • 2,500,000 medicines (Rx and OTC) - full information about each drug including - Ex-factory, Tender, Wholesale and retail prices + reimbursed information. • Tender awarded results and pricing levels. • Active ingredients, ATC code classification, administration routes, strength, trade names, MA holder information and more. • Niche market product locator. • Market Opportunity Locator business tool. Live track the molecules with the least competition per country. • Consumption and sales data for USA, EU5, Scandinavia, Baltics, Canada and more. • Full European parallel import information. EMA and National levels. • National medicine shortages tracker. • First approval date and marketing authorizations for all molecules from USA, Europe. • Standard monthly updates. • Excel downloads. • Real manufacturer information. • Live track first generic registrations of patented medicines as they happen. • Most competitive and affordable yearly membership costs!
